Last $50.56 USD
Change Today +0.14 / 0.28%
Volume 5.9M
BMY On Other Exchanges
Symbol
Exchange
New York
Mexico
Sao Paulo
Frankfurt
As of 8:04 PM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sandra Leung

General Counsel and Corporate Secretary, Bristol-Myers Squibb Company
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 3 different industries.

See Board Relationships
53$4,816,287
As of Fiscal Year 2013

Background*

Ms. Sandra Leung, also known as Sandy, has been General Counsel and Secretary of Bristol-Myers Squibb Co. since February 15, 2007 and 1999 respectively. Ms. Leung served as an Interim General Counsel of Bristol-Myers Squibb Co. from September 12, 2006 to February 15, 2007, Vice President from 2002 to February 15, 2007 and served as its Senior Vice President. She joined Bristol-Myers Squibb in 1992 as a Staff Attorney in the Litigation Group. Prior to joining Bristol-Myers, ...

Read Full Background

Corporate Headquarters*

345 Park Avenue
New York, New York 10154

United States

Phone: 212-546-4000
Fax: 212-546-4020

Board Members Memberships*

2007-N/A
Former Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
2009-Present
Director

Education*

Bachelor's Degree
Tufts University
LLB
Boston College

Other Affiliations*

Annual Compensation*

Salary$843,087
Total Annual Compensation$843,087

Stock Options*

Restricted Stock Awards$2,883,914
All Other Compensation$245,048
Exercised Options19,310
Exercised Options Value$265,128
Exercisable Options587,135
Exercisable Options Value$18,020,464
Total Value of Options$18,285,591
Total Number of Options606,445

Total Compensation*

Total Annual Cash Compensation$1,932,373
Total Short Term Compensation$843,087
Other Long Term Compensation$3,128,962
Total Calculated Compensation$4,816,287
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMY:US $50.56 USD +0.14

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRISTOL-MYERS SQUIBB CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.